These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6975136

  • 1. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT, Dunne JV.
    Blood; 1981 Nov; 58(5):1043-6. PubMed ID: 6975136
    [Abstract] [Full Text] [Related]

  • 2. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.
    Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI.
    J Clin Oncol; 1987 Dec; 5(12):1900-11. PubMed ID: 3500279
    [Abstract] [Full Text] [Related]

  • 3. The relative sensitivity of peripheral blood T-lymphocyte colony forming cells and bone marrow CFU-GM to deoxyadenosine and 2'deoxycoformycin.
    Russell NH, Carron J, Hoffbrand AV, Bellingham AJ.
    Leuk Res; 1985 Dec; 9(2):315-9. PubMed ID: 3872974
    [Abstract] [Full Text] [Related]

  • 4. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT, Dunne JV, Yang WC.
    Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT, Sutherland DE, Najarian JS.
    Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
    [No Abstract] [Full Text] [Related]

  • 6. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
    Holland MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
    [Abstract] [Full Text] [Related]

  • 7. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
    Trotta PP, Tedde A, Ikehara S, Pahwa R, Good RA, Balis ME.
    Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
    [Abstract] [Full Text] [Related]

  • 8. Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
    Ratech H, Kuritsky L, Thorbecke GJ, Hirschhorn R.
    Cell Immunol; 1982 Apr; 68(2):244-51. PubMed ID: 6980056
    [No Abstract] [Full Text] [Related]

  • 9. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 10. Action of deoxycoformycin on human T cell colonies in vitro.
    Colledge NR, Krajewski AS, Smyth JF, Wyllie AH.
    Clin Exp Immunol; 1982 Oct; 50(1):115-22. PubMed ID: 6983406
    [Abstract] [Full Text] [Related]

  • 11. Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.
    Brox LW, Pollock E, Belch A.
    Cancer Chemother Pharmacol; 1982 Oct; 9(1):49-52. PubMed ID: 6982786
    [Abstract] [Full Text] [Related]

  • 12. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD, Ganeshaguru K, Knauf W, Dietz G, Trede I, Hoffbrand AV, Hunstein W.
    Leuk Res; 1989 Oct; 13(4):269-78. PubMed ID: 2785618
    [Abstract] [Full Text] [Related]

  • 13. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 14. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
    Faltynek CR.
    Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
    [Abstract] [Full Text] [Related]

  • 15. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
    Romo A, Lorente F, Salazar V.
    Allergol Immunopathol (Madr); 1988 Jan; 16(4):243-7. PubMed ID: 3265855
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR, Overgaard-Hansen K, Frederiksen S.
    Cancer Chemother Pharmacol; 1988 Jan; 21(1):35-9. PubMed ID: 3257721
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
    Kuroki Y, Shimoyama M, Inaba S, Hirose M.
    Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
    [Abstract] [Full Text] [Related]

  • 18. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV.
    Br J Haematol; 1984 Jan 01; 56(1):107-19. PubMed ID: 6231047
    [Abstract] [Full Text] [Related]

  • 20. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
    Hoffee PA, Hunt SW, Chiang J.
    Somatic Cell Genet; 1982 Jul 01; 8(4):465-77. PubMed ID: 6981855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.